Rickettsia slovaca and Rickettsia raoultii have been associated with a syndrome characterized by scalp eschar and neck lymphadenopathy following tick bites. However, in many cases, the causative agent remains undetermined. We report 3 cases of this syndrome caused by Bartonella henselae, and we propose the term "SENLAT" to collectively describe this clinical entity.
In 1997, Rickettsia slovaca was identified as the cause of a clinical entity associated with scalp eschar and neck lymphadenopathy after tick bite [1] . Lakos proposed the name "TIBOLA" (tickborne lymphadenopathy) to describe a series of 27 patients who were likely infected with R. slovaca, with scalp eschar and lymphadenopathy [2] . In 2002, Raoult et al [1] reported a series of 67 patients with the same findings, of whom only 17 had definitive evidence of R. slovaca infection. The same year, Lakos [2] identified only 19 cases of R. slovaca infection among 73 patients with scalp eschar and neck adenopathy. In Spain, a similar disease, named "DEBONEL" (Dermacentor-borne necrosis-erythema-lymphadenopathy) was described in patients with scalp eschars and painful regional lymphadenopathy [3] . We propose the name "SENLAT" (scalp eschar and neck lymphadenopathy after tick bite) to describe this syndrome. However, these infections were not definitely confirmed to be due to R. slovaca.
In 2005, Ibarra et al [3] proposed that some cases of SENLAT are probably caused by other Rickettsia species, and in 2006, they identified DNA of what is now known to be Rickettsia raoultii in blood specimens obtained from a patient. Recently, Parola et al [4] also confirmed that R. raoultii can cause SEN-LAT. They also found 2 patients who were coinfected with R. slovaca and Coxiella burnetii in an acute form of Q fever. However, in 28 patients, the specific bacterial agent causing this syndrome was not determined. These data indicate collectively that other causes of the syndrome characterized by scalp eschar and neck adenopathy remain unknown. As a national reference center for rickettsioses and bartonelloses, we receive skin biopsy and serum specimens from patients with SENLAT. These specimens are routinely tested for Rickettsia species, Bartonella species, C. burnetii, Borrelia burgdorferi, and Francicella tularensis by using serologic, molecular, and culture-based techniques.
Methods. From January 2008 through June 2009, we tested 28 patients for SENLAT, including 6 male patients and 22 female patients, who ranged from 3 years to 58 years of age. Tick bites occurred most frequently during October and November (11 [39%] of 28) and during April and May (10 [36%] of 28). No cases occurred between June and September. Western blot and cross-adsorption analyses allowed the detection of antibodies specifically directed against R. slovaca and R. raoultii; antibodies were present in 15 (53%) of 28 patients and 3 (10.7%) of 28 patients, respectively. The specific bacterial agent causing SENLAT was not determined for 7 patients (25%). However, for 3 patients (10.7%), we identified infection due to Bartonella henselae (Table 1) .
From each of these 3 patients, we received an eschar biopsy specimen and paired serum samples. For 1 patient, we also received a tick that had been removed from the patient's scalp. Epidemiological and clinical data were also collected. DNA was extracted from the tissue biopsy specimens and from the tick using a QIAamp tissue kit (Qiagen). The DNA was used as a template in a previous described reverse-transcription (RT) polymerase chain reaction (PCR) assay targeting a portion of the Bartonella 16S-23S intergenic spacer region, as well as the PAP31 gene, for the detection of B. henselae [5] ; the RKND03 gene, for the detection of Rickettsia species; and 12S rRNA, to identify the tick [6] . Immunoglobulin (Ig) G and IgM antibody titers reactive with spotted fever and typhus group rickettsiae, Bartonella species, B. burgdorferi, F. tularensis, and C. burnetii antigens were determined by an immunofluorescence antibody assay (IFA) and validated by Western blot [7] . Detailed histories for each patient are described below. Case report. Patient 1 was a 35-year-old pregnant woman with asthenia who had been bitten by a female tick on the scalp in May 2009. PCR analysis of the tick using a 12S rRNA sequence revealed that the species was Dermacentor marginatus (GenBank AM410570). The patient did not own a pet and did not report contact with animals. During the examination, an eschar was found at the site of the tick bite that was associated with bilateral cervical lymphadenopathy but no other specific findings. By using a real-time PCR assay, segments of the B. henselae intergenic spacer region and PAP31 genes were identified in the tick specimen. The eschar biopsy was performed ∼1.5 months after the tick bite and was negative for B. henselae DNA when tested with the real-time PCR assay. Rickettsia DNA was not identified in the tick or the skin biopsy specimen. No antibodies reactive with Bartonella species, C. burnetii, B. burgdorferi, Rickettsia species, or F. tularensis were detected by IFA; however, Western blot was positive for B. henselae. The patient was treated with josamycine for 15 days, and after 1 month, the eschar and the lymphadenopathy had disappeared. No alopecia at the eschar site was observed.
Patient 2 was a 48-year-old female equestrian who had been bitten by a tick in November 2008 and who developed persistent asthenia. She described frequent contacts with cats and horses. Physical examination revealed an eschar on her scalp, bilateral cervical lymphadenopathy, and no other specific findings. Blood cell counts and liver enzyme levels were normal. B. henselae DNA was detected in the eschar biopsy specimen by PCR; no Rickettsia DNA was present in the specimen. A serum sample demonstrated antibodies reactive only with B. henselae (IgG titer, 1:512) and was negative for C. burnetii, B. burgdorferi, Rickettsia species, and F. tularensis; the result was confirmed by Western blot. The patient was treated with doxycycline, and her lymphadenopathy resolved within 2 weeks. No alopecia at the eschar site was observed.
Patient 3 was a 20-year-old man who presented with asthenia, an eschar on the scalp, and left occipital lymphadenopathy. The patient owned a cat and also had contact with horses and cows. He mentioned that he was probably bitten by a tick during November 2008. Physical examination revealed numerous tick bites, although no other specific findings were found. Blood cell counts and liver enzyme levels were normal. B. henselae DNA was identified by RT-PCR in the skin biopsy specimen of the eschar. RT-PCR was negative for Rickettsia species. A serum sample demonstrated antibodies reactive only with B. henselae (IgG titer, 1:2048) and negative for C. burnetii, B. burgdorferi, Rickettsia species, and F. tularensis; the result was confirmed by Western blot. The patient's eschar and lymphadenopathy resolved after 6 weeks of treatment with doxycycline. No alopecia at the eschar site was observed Discussion. In this report, we identified 3 patients with SENLAT who seroconverted to B. henselae and 1 patient with negative IFA and positive Western blot results after a tick bite. Serum samples negative by IFA and positive by Western blot can be observed during the onset of the disease [8] . On the basis of molecular methods, we confirmed that the eschar biopsy specimens from 2 of the patients also contained DNA of B. henselae and that an attached Dermacentor tick form one of the patients contained DNA of B. henselae. Each of the patients with SENLAT were bitten by ticks during colder months, consistent with activity of Dermacentor ticks in Europe and with the observation that SENLAT cases are not recorded during the warmest summer months [4] . From these data we believe that B. henselae is likely the cause of these 3 cases of SENLAT.
R. slovaca and R. raoultii have been detected in or isolated from Dermacentor ticks in Eurasia, which inhabit forests and pastures, and frequently bite people, particularly on the scalp [4] . During recent years, molecular epidemiology surveys throughout the world suggest that ticks are competent vectors of Bartonella species [9] . The presence of Bartonella species, in most cases, has been identified using PCR analysis using primers targeting either specific Bartonella genes or the 16S rDNA gene and results revealed that the proportion of ticks harboring Bartonella DNA is variable [9] . However, only Kruszewska and Tylewska-Wiezbanowska [10] achieved the isolation of Bartonella species from a tick. Direct proof of transmission of Bartonella species by a tick was reported by Noguchi in 1926, who described experimental transmission of Bartonella bacilliformis to monkeys by Dermacentor andersoni. Recently, Cotté et al [11] published a report detailing the potential transmission of B. henselae by Ixodes ricinus ticks in an experimental model. Ticks have long been considered a potential source of B. henselae infection based on epidemiological evidence [9] ; however, this topic is still subject of discussion. Transmission of B. henselae from a tick to a human host has not yet been proved, and only circumstantial evidence of tick transmission has been reported [9] .
SENLAT is a common clinical entity that occurs most frequently in women and children during the colder months and is caused by R. slovaca, R. raoultii, and possibly also B. burgdorferi [2] . We believe that the designations "TIBOLA" and "DEBONEL," which were proposed initially for this clinical entity, are not inclusive of the growing number of infectious agents causing a scalp eschar and neck lymphadenopathy following tick bite. We propose a new name of this syndrome (SENLAT) that is independent of a specific etiologic agent, and we have found that the spectrum of the causative agents of SENLAT should be extended. Other agents of SENLAT may also exist, because in many cases (25% in this series), the causative agent remains undetermined. The report and others [12] indicate that the clinical spectrum caused by B. henselae continues to expand.
